Forte Biosciences | 8-K:重大事件
Forte Biosciences | SCHEDULE 13G:其他
Forte Biosciences | 4:持股变动声明-高管 Wagner Paul A.
Forte Biosciences | 4:持股变动声明-高管 Riley Antony A
Forte Biosciences | DEF 14A:股东委托书决议
Forte Biosciences | EFFECT:其他
Forte Biosciences | 424B3:募资说明书
Forte Biosciences | CORRESP:信函
Forte Biosciences | UPLOAD:其他
Forte Biosciences | S-3:特定交易注册声明
Forte Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Alger Associates, Inc.(15.0%)
Forte Biosciences | 8-K:重大事件
Forte Biosciences | 4:持股变动声明-高管 Riley Antony A
Forte Biosciences | 8-K:重大事件
Forte Biosciences | 8-K:FORTE BIOSCIENCES, INC.公布2024年第三季度业绩并提供业务最新情况
Forte Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Alger Associates, Inc.(5.7%)
Forte Biosciences | SC 13G/A:超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(9.99%),Joseph Edelman(9.99%)等
Forte Biosciences | 10-Q:2024财年三季报
Forte Biosciences | 4:持股变动声明-高管 Riley Antony A
Forte Biosciences | 4:持股变动声明-高管 Wagner Paul A.